z-logo
Premium
Creb coactivators direct anabolic responses and enhance performance of skeletal muscle
Author(s) -
Bruno Nelson E,
Kelly Kimberly A,
Hawkins Richard,
BramahLawani Mariam,
Amelio Antonio L,
Nwachukwu Jerome C,
Nettles Kendall W,
Conkright Michael D
Publication year - 2014
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1002/embj.201386145
Subject(s) - library science , jupiter (rocket family) , engineering , computer science , space shuttle , aerospace engineering
During the stress response to intense exercise, the sympathetic nervous system ( SNS ) induces rapid catabolism of energy reserves through the release of catecholamines and subsequent activation of protein kinase A ( PKA ). Paradoxically, chronic administration of sympathomimetic drugs (β‐agonists) leads to anabolic adaptations in skeletal muscle, suggesting that sympathetic outflow also regulates myofiber remodeling. Here, we show that β‐agonists or catecholamines released during intense exercise induce Creb‐mediated transcriptional programs through activation of its obligate coactivators Crtc2 and Crtc3. In contrast to the catabolic activity normally associated with SNS function, activation of the Crtc/Creb transcriptional complex by conditional overexpression of Crtc2 in the skeletal muscle of transgenic mice fostered an anabolic state of energy and protein balance. Crtc2‐overexpressing mice have increased myofiber cross‐sectional area, greater intramuscular triglycerides and glycogen content. Moreover, maximal exercise capacity was enhanced after induction of Crtc2 expression in transgenic mice. Collectively these findings demonstrate that the SNS ‐adrenergic signaling cascade coordinates a transient catabolic stress response during high‐intensity exercise, which is followed by transcriptional reprogramming that directs anabolic changes for recovery and that augments subsequent exercise performance.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here